Table 4.

Distribution of scores representing the quality of recovery in TG^a 1: ketamin–medetomidin–midazolam–butorphanol (KMMB), TG 2: tiletamine–zolazepam–medetomidin–butorphanol and CG^b: etorphine–acepromazine–detomidin–butorphanol (EADB) immobilized kulans (Equus hemionus kulan).

Recovery quality scores	1	2	3	4
Description	Excellent	Good	Fair	Poor
Attempts to stand	<2	> 2	numerous	Not staying in recumbency, darting again or handinjection
Level of ataxia/ tremors	Slight to none	Moderate	Severe	None, requires clinical examination
Group	Number of animals				Scores
TG 1	6	2	0	0	1 ± 0.164
TG 2	6	1	0	0	1 ± 0.143
Control	6	0	0	0	1 ± 0*†d

Values are reported as median (± SE^c range).

^aTG, treatment group;

^bCG, control group;

^cSE, standard error;

^cna, not applicable: missing values as no measurements available;

^{d *}Significantly different to KMMB at this timepoint (p < 0.05);

^†Significantly different to TZMB at this timepoint (p < 0.05).